Steroid In Esophageal Sticture

Not yet recruiting

• Conditions: Other specified diseases of esophagus,

• Registration Number: CTRI/2021/10/037410
• Lead Sponsor: Chacha Nehru Bal Chikitsalaya

Brief Summary

This is a randomized controlled trial of role of intralesional steroid in esophageal stricture dilatation. Its  single blinded trial. It will include children with esophageal stricture requiring more than three dilatation to maintain their luminal patency with the age group between 6 months to 12 years.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-10-20
• Study Start: 2021-10-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Children having esophageal stricture and requiring more than three dilatation.

Exclusion Criteria

Long and Multiple Strictures Post Sclerotherapy Strictures.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare number of dilatations in patients of benign refractory or recurrent esophageal stricture receiving intralesional steroid injection with dilatation or dilatation alone which will be measured as periodic dilatation index.	After four sessions dilatation

Secondary Outcome Measures

Name	Time	Method
-To compare the level of dysphagia and the child’s eating behaviour between the two groups.	-To compare the effect of intralesional steroid injections on the luminal diameter and the stricture length between the two groups.

Trial Locations

Locations (1)

Pediatric Gastroenterology Division of Chacha Nehru Bal Chikitsalaya (Room No 417- Endoscopy Room)); 🇮🇳 East, DELHI, India

Pediatric Gastroenterology Division of Chacha Nehru Bal Chikitsalaya (Room No 417- Endoscopy Room))

🇮🇳East, DELHI, India

Anuradha Rai

Principal investigator

8800674851

anuradharai2@gmail.com